There’s no doubt that the Sunshine Act provisions of the Affordable Care Act, which require pharmaceutical companies to track and publicly report what they spend on U.S. healthcare providers, will make life more difficult for life sciences meeting planners. But it gets even more complicated when you take your meetings
"World Flags" by David Castillo Dominici/FreeDigitalPhotos.net
Tracking Global Physician Spend
Taking a pharmaceutical meeting outside the U.S. can get complicated as you have to consider the meeting's host country's rules around payments to healthcare providers, as well as those of the HCPs' home countries. This article offers a country-by-country snapshot of HCP-related rules and codes, and tips on other things to consider when planning a meeting for HCPs outside of the U.S.